A PET-CT scan on June 5, 2023, confirmed complete remission in a patient with advanced gastric adenocarcinoma expressing high levels of PD-L1, who had received PD-L1-specific immune therapy in combination with chemotherapy. The gene discussed is CD274; the disease is gastric adenocarcinoma.